Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Clin Genet. 2016 Nov 24;91(6):824–831. doi: 10.1111/cge.12893

Table 3. Characteristics of Tested Subjects by CAG Status (N = 87).

CAG <37 (N = 47) CAG ≥37 (N = 40) P-Value
SCORES AT PRIOR VISIT
 UHDRS Motor Score 0 (0, 3) 3 (0, 12) 0.0009
 UHDRS Chorea Score 0 (0, 0) 1 (0, 4) 0.0005
 Beck Depression Score 3 (1, 8) 5 (1, 13) 0.71
 UHDRS Behavioral Score (Frequency × Severity) 3 (0, 10) 5.5 (2, 19.5) 0.07
SCORES AT VISIT WHEN TESTING WAS DISCLOSED
 UHDRS Motor Score 1 (0, 2) 5 (2, 14.5) <0.0001
 UHDRS Chorea Score 0 (0, 0) 0 (0, 3.5) 0.0016
 Beck Depression Score 3 (0, 5) 3 (1, 10.5) 0.12
 UHDRS Behavioral Score (Frequency × Severity) 2 (0, 6) 7 (0, 13) 0.0379
CHANGES FROM PRIOR VISIT
 Change in UHDRS Motor Score 0 (0, 0) 0 (-1, 4) 0.0016
 Change in UHDRS Chorea Score 0 (0, 0) 0 (0, 1) 0.17
 Change in Beck Depression Score -1 (-3, 0) 0 (-2, 3) 0.0286
 Change in UHDRS Behavioral Score (Frequency × Severity) 0 (-4, 2) -0.5 (-6, 2.5) 0.31

Values shown are medians (25%, 75% percentiles). P-values indicate the significance levels for comparisons by CAG status using Kruskal-Wallis tests for the scores at each visit, and analysis of covariance on the ranks, including the prior visit score, was used for the change scores.